Our Vital Organ Support Therapies
Our journey at Vantive began 70 years ago, when we produced the first commercially available dialysis system. We introduced peritoneal dialysis (PD) for patients at home, and we have been a transformative force in both continuous renal replacement therapy (CRRT) and hemodialysis (HD). We are committed to advancing these therapies today with the goal of extending lives and improving patient quality of life.
PD
Peritoneal dialysis — combined with remote patient management and dedicated services — offers the potential to improve kidney patients’ clinical outcomes and increase lifestyle flexibility.
HD
Hemodialysis delivered through innovative products helps simplify workflow, protect patient safety and drive operational efficiency.
HDx Therapy
HDx therapy, delivering expanded hemodialysis — the next evolution in dialysis — targets removal of large-middle molecules and brings us one step closer to the natural kidney.1
CRRT
Continuous Renal Replacement Therapy for patients experiencing acute kidney injury.
TPE
Therapeutic plasma exchange — an extracorporeal blood purification technique designed for the removal of pathogenic large molecular weight substances through blood plasma filtration, along with administration of a plasma replacement fluid.
ECCO2R Therapy
Helps prevent the dangers of hypercapnia and facilitate the benefits of lung-protective ventilation (LPV)2,3.
Join us and stay informed
Stay up to date on the therapy and product innovations that matter most to you. Connect with a Vantive representative to find the right solutions for your organization.
Vantive, AK 98, AN69, HDx, Prismaflex, PrisMax and Theranova are trademarks of Vantive Health LLC or its affiliates.
References
-
Zweigart C, Boschetti-de-Fierro A, Hulko M, et al. Medium cut-off membranes — closer to the natural kidney removal function. Int J Artif Organs. 2017;40(7):328-334.
-
Combes A, Auzinger G, Camporota L, et al. Expert perspectives on ECCO2R for acute hypoxemic respiratory failure: consensus of a 2022 European roundtable meeting. Ann Int Care. 2024;14:132.
-
Ferrer Gomez C, et al. J Pers Med. 2023;3:1081.